Blackmores to acquire facility from Catalent

24 April 2018 - Deborah Wilkes

Archived

Blackmores has agreed to acquire an Australian tablet and softgel capsule manufacturing facility from Catalent for around AUD43.2 million (USD32.7 million). The Australian natural health specialist said the transaction would give it "increased agility to respond to changing marketing conditions" and "future-proof its Asian business".

Annual Subscription Holder?

Sign in to continue reading.
 

Sign In

Back to Industry News

Share this page: